UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000023646
Receipt No. R000026587
Scientific Title A phase II study evaluating immune-priming effect of Nivolumab in combination with palliative radiationtherapy in previously treated patients with non-small cell lung cancer.
Date of disclosure of the study information 2016/08/16
Last modified on 2019/08/20 16:24:11

No. Disposal Last modified on Item of update
1 Insert 2016/08/16 21:02:25
2 Update 2016/08/17 22:11:43 Organization
Organization
Category of Funding Organization
3 Update 2016/11/19 15:22:38 Last name of lead principal investigator
Last name of lead principal investigator
4 Update 2019/02/18 10:05:24 Recruitment status
Last follow-up date
5 Update 2019/08/20 16:19:15 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Institute
Institute
Department
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/08/20 16:20:14 Number of participants that the trial has enrolled
7 Update 2019/08/20 16:24:11 Date of IRB


Contact us.